ClinicalTrials.Veeva

Menu

Effectiveness of Repeated Amiodarone Dosing Regimen Versus Standard Dosing Regimen in Atrial Fibrillation Patient With Rapid Ventricular Response

P

Police General Hospital, Thailand

Status and phase

Completed
Phase 4

Conditions

Atrial Fibrillation

Treatments

Drug: Amiodarone

Study type

Interventional

Funder types

Other

Identifiers

NCT06262932
RADS regimen

Details and patient eligibility

About

The goal of this clinical trial is to compare in atrial fibrillation patient with rapid ventricular response. The main question it aims to answer are Effectiveness of Repeated Amiodarone dosing regimen versus standard dosing regimen in Atrial fibrillation patient with rapid ventricular response Participants will receive Amiodarone iv treatment with different regimen

  • Repeated dosing regimen
  • Standard dosing regimen

Enrollment

24 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age above 18 years old
  • Atrial fibrillation with rapid ventricular response patient (ventricular rate > 110)

Exclusion criteria

  • Baseline EKG Corrected QT interval (QTc) < 500 msec
  • History of pulmonary fibrosis
  • History of Cirrhosis
  • Cardiac Index <2.2 L/min/m2 or Cardiogenic shock
  • Unstable arrhythmia
  • Receive amiodarone within 3 months prior to present illness
  • Pregnancy
  • Amiodarone or Iodine allergy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

24 participants in 2 patient groups

Repeated amiodarone bolus dosing regimen
Active Comparator group
Description:
An Initial 150 mg IV amiodarone bolus should be given over a 15-minute period. If the heart rate is still over 110 minutes after the initial treatment, provide an additional 150 mg IV amiodarone bolus over a 15-minute period. During the first 24 hours, this bolus may be administered up to three times in total. Within 24 hours of finishing the first bolus dosage, 900 mg of amiodarone will be administered intravenously.
Treatment:
Drug: Amiodarone
Standard dosing regimen
Active Comparator group
Description:
An Initial 150 mg IV amiodarone bolus should be given over a 15-minute period, then a 24-hour amiodarone loading infusion 900 mg over 24 hours
Treatment:
Drug: Amiodarone

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems